
Hyponet O 30mg Tablet
Marketer
Cadila Healthcare Limited
Salt Composition
Tolvaptan (30mg)
Overview Hyponet O 30mg Tablet
Sodiumion 30mg tablets are indicated for the management of hyponatremia. This medication addresses low blood sodium levels, often associated with conditions like congestive heart failure, liver cirrhosis, and SIADH. Sodiumion 30mg tablets may be administered with or without food, strictly as directed by your physician. Dosage and frequency will be determined individually. Consistent use is crucial for optimal therapeutic effect; discontinue only under your doctor's guidance. Commonly reported side effects include increased urinary frequency, nocturia, xerostomia, polydipsia, nausea, elevated creatinine levels, hyperkalemia, and constipation. Report any persistent or worsening side effects to your doctor. Prior to commencing treatment, disclose any kidney or liver dysfunction. Your doctor will regularly monitor your serum sodium levels during therapy. A complete list of all concurrently used medications should also be provided to your physician.
Uses of Hyponet O 30mg Tablet
Managing hyponatremia
Major Benefits of Hyponet O 30mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Hyponet O 30mg Tablets can be administered with or without food, though consistent timing is recommended.
Common Side effects of Hyponet O 30mg Tablet:
- Frequent urge to urinate
- Nocturia (increased urge to urinate during the night)
- Dryness in mouth
- Increased thirst
- Constipation
- Nausea
- Increased creatinine level in blood
- Increased potassium level in blood
How to use Hyponet O 30mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Hyponet O 30mg Tablets can be consumed with or without food, although consistent timing is recommended.
How Hyponet O 30mg Tablet works:
Tolvaptan 30mg tablets counteract the action of vasopressin, a hormone that regulates fluid balance. By inhibiting vasopressin's effects, they promote diuresis, lowering blood volume and consequently elevating serum sodium concentration.
SAFETY ADVICE
AlcoholCAUTION
Use of alcohol alongside Hyponet O 30mg Tablets requires careful consideration. Physician consultation is recommended.
PregnancyCONSULT YOUR DOCTOR
The use of Hyponet O 30mg tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the fetus. A physician will assess the benefits against possible risks prior to prescribing. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
The use of Hyponet O 30mg tablets while breastfeeding is likely inadvisable. Available data from human studies indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Taking a 30mg Hyponet O Tablet might reduce alertness, impair vision, or cause drowsiness and dizziness. Refrain from driving if you experience these effects.
KidneySAFE IF PRESCRIBED
Hyponet O 30mg tablets may be used by patients with kidney disease without dosage modification. Nevertheless, administration of Hyponet O 30mg tablets is contraindicated in individuals with severely impaired kidney function.
LiverCAUTION
Patients with liver impairment should exercise caution when using Hyponet O 30mg Tablets; dosage modification may be necessary. Consult a physician for guidance. Hyponet O 30mg Tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Hyponet O 30mg Tablet :
Should you forget to take a Hyponet O 30mg Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed tablet and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Hyponet O 30mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Benzazepine-based compound |
| Developing Habits | No. |
| Treatment Category | Urology |
| Action Class | Vasopressin receptor blocker |
